NCT02805075View on ClinicalTrials.gov

Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 17, 2017

Study Completion Date

November 17, 2017

Conditions
Hematopoietic and Lymphoid Cell NeoplasmRecurrent Hematologic Malignancy
Interventions
OTHER

Fructooligosaccharide

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

94304

Stanford University, School of Medicine, Palo Alto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Stanford University

OTHER

NCT02805075 - Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter